RUBICON2026-01-14RUBICON2026-01-142026-01-14xbrli:pureRUBICONRubicon Research LimitedNewIncorporation2026-01-132026-01-14Rubicon Research LimitedSubsidiaryAdvaGen S A CompanyPharmaceuticalsDealing in pharmaceutical products.Cost/PriceSAR 1,00,000 (100 equity shares of face value of SAR 1,000 each)12026-01-13Saudi ArabiaNA